Abstract
 Anticipation in the age at onset of cancer in successive generations was described in several familial cancer syndromes. Based on multiple statistical analyses of a database of families with germline TP53 mutations, and using several different approaches and measures to eliminate possible biases, we show that anticipation may be a feature of the Li-Fraumeni syndrome. Definitive proof of anticipation in pedigrees with germline TP53 mutations will require more family data and further analysis, as well as research on the role of the p53 protein in processes like genome stability, which may represent the biological basis of anticipation in these families. This should have important practical implications for genetic testing, counselling, and preventative care for individuals at risk.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: February 19, 2002 / Accepted: April 15, 2002
Rights and permissions
About this article
Cite this article
Trkova, M., Hladikova, M., Kasal, P. et al. Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?. J Hum Genet 47, 381–386 (2002). https://doi.org/10.1007/s100380200055
Issue Date:
DOI: https://doi.org/10.1007/s100380200055
This article is cited by
-
Li–Fraumeni syndrome heterogeneity
Clinical and Translational Oncology (2020)
-
Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family
npj Genomic Medicine (2018)
-
Number of rare germline CNVs and TP53 mutation types
Orphanet Journal of Rare Diseases (2012)
-
Increased severity over generations of Charcot-Marie-Tooth disease type 1A
Journal of Neurology (2008)
-
Mammary tumor modifiers in BALB/cJ mice heterozygous for p53
Mammalian Genome (2007)